Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Cyprotex

7 Apr 2016 13:42

RNS Number : 5335U
Charles Stanley & Co. Ltd.
07 April 2016
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Dr S Toon

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cyprotex PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

7th April 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

255,462

1.13

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

255,462

1.13

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

07th April 2016

Contact name:

Dr Steve Toon

Telephone number:

07799115200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETLLFSFSFIDIIR
Date   Source Headline
14th Dec 20164:03 pmRNSScheme of Arrangement becomes effective
14th Dec 20167:30 amRNSSuspension - Cyprotex Plc
13th Dec 20163:32 pmRNSDirector Dealing
13th Dec 201611:46 amRNSCourt Sanction of Scheme of Arrangement
9th Dec 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Dec 201610:02 amRNSForm 8.5 (EPT/RI) Cyprotex plc
6th Dec 20169:04 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex Plc
5th Dec 20169:12 amRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:45 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:37 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20168:45 amRNSForm 8.3 - Cyprotex PLC
1st Dec 20161:40 pmRNSResults of Court Meeting & General Meeting
1st Dec 20169:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
1st Dec 20168:23 amRNSForm 8.3 - Cyprotex PLC
30th Nov 20169:06 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 201610:31 amRNSForm 8.3 - CYPROTEX PLC
29th Nov 20169:46 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 20167:00 amRNSLaunch of in vitro h-CLAT Service
28th Nov 201610:52 amRNSForm 8.3 - CYPROTEX PLC
28th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
25th Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex plc
23rd Nov 20169:17 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
22nd Nov 20169:05 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
21st Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
16th Nov 20169:24 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
15th Nov 20168:39 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
14th Nov 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
11th Nov 20167:00 amRNSDirector Dealing
10th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
9th Nov 20169:53 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
8th Nov 201610:01 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Nov 20169:27 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
4th Nov 20167:00 amRNSPosting of Scheme Document
2nd Nov 201610:09 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
1st Nov 20169:09 amRNSForm 8.5 (EPT/RI) Cyprotex
27th Oct 201612:39 pmRNSForm 8.5 (EPT/RI) CYPROTEX PLC
27th Oct 201610:11 amPRNForm 8.3 - Cyprotex Plc - Amendment
26th Oct 20169:08 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
26th Oct 20167:00 amRNSRule 2.7 Announcement: Recommended Offer
25th Oct 20169:23 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
21st Oct 20163:31 pmRNSDirector Declaration
21st Oct 20169:59 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
20th Oct 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Oct 20169:22 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
14th Oct 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20169:46 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20167:00 amRNSCyprotex PLC - Rule 2.9 Announcement
11th Oct 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.